<DOC>
	<DOCNO>NCT02176317</DOCNO>
	<brief_summary>This study prospective phase 1 single-center trial design determine safety single intravenous infusion autologous umbilical cord blood child Autism Spectrum Disorder ( ASD ) ass feasibility various outcome measure determine measure ( ) use primary secondary endpoint future randomize phase 2 clinical trial . All subject receive infusion cord blood cell baseline follow assessment 6 12 month .</brief_summary>
	<brief_title>Autologous Umbilical Cord Blood Infusion Children With Autism Spectrum Disorder ( ASD )</brief_title>
	<detailed_description>Autism Spectrum Disorder ( ASD ) neurodevelopment disorder early onset life . Currently , available treatment patient ASD supportive , curative . Umbilical cord blood ( UCB ) show lessen clinical radiographic impact hypoxic brain injury stroke animal model infant hypoxic ischemic encephalopathy . UCB also engraft differentiates brain , facilitate neural cell repair animal model human patient inborn error metabolism undergo allogeneic , unrelated donor UCB transplantation . Infusion autologous UCB require immunosuppression show safe young child brain injury cerebral palsy stroke . In study , investigator hypothesize infusion patient 's umbilical cord blood cell ( UCB ) offer neural protection/repair brain reduction inflammation associate disorder .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Child Development Disorders , Pervasive</mesh_term>
	<criteria>1 . Age ≥ 24 month ≤72months time visit 1 2 . Confirmed clinical DSM5 diagnosis Autism Spectrum Disorder use three follow measure : Autism Diagnostic Observation Schedule Toddler Generic ( ADOS ) Autism Diagnostic InterviewRevised ( ADIR ) DSM5 checklist 3 . IQ ≥ 35 Stanford Binet Intelligence Scale similar standardize test 4 . Autologous umbilical cord blood available cord blood bank minimum total nucleate cell dose ≥ 1 x 107 cells/kilogram subject weight meet acceptance criterion outline section 6.0 confirm HLA match 5 . Stable current medication least 2 month prior infusion cord blood 6 . Ability travel Duke University three time ( 0 , 6 , 12 mo . ) , parent/guardian able participate electronic communication track two time study interim phone survey every 3 month 7 . Parental consent 8 . Subject parent/guardian must English speak 1 . Unwilling commit follow year 2 . History prior cell therapy 3 . Use IVIG antiinflammatory medication exception NSAIDs 4 . Medical record indicate child genetic syndrome fragile X , neurofibromatosis , Rett syndrome , tuberous sclerosis , PTEN mutation , cerebral palsy , cystic fibrosis , muscular dystrophy , Crohn 's disease , rheumatoid disease 5 . Central Nervous System ( CNS ) infection 6 . History unstable epilepsy uncontrolled seizure disorder , infantile spasm , Lennox Gastaut syndrome , Dravet syndrome 7 . Known pathogenic copy number variation ( CNV ) ( e.g . 16p11.2 , 15q13.2 , 2q13.3 ) 8 . Significant sensory ( i.e. , deafness , blind ) motor impairment ( CP ) ( use Language Environment Analysis ( LENA ) , uncorrected hearing impairment ) 9 . Presence obvious physical dysmorphology 10. Review medical record indicate ASD diagnosis likely serious complicate genetic medical condition present 11 . Impaired renal liver function determine serum creatinine &gt; 1.5mg/dL and/or total bilirubin &gt; 1.3mg/dL 12 . Clinically significant abnormality Complete Blood Count ( CBC ) : Hemoglobin &lt; 10.0 g/dL , White Blood Count ( WBC ) &lt; 3.8 x 10e9 , Platelets &lt; 150x 10e9 . 13 . Initiation intensive behavior intervention anticipate study 14 . Known metabolic disorder , mitochondrial dysfunction 15 . Uncontrolled infection , presence infection HIV 16 . Active malignancy 17 . Macroencephaly microencephaly 18 . Change current stable use psychoactive medication ; per parent report .</criteria>
	<gender>All</gender>
	<minimum_age>24 Months</minimum_age>
	<maximum_age>72 Months</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Autism Spectrum Disorder</keyword>
	<keyword>ASD</keyword>
	<keyword>Umbilical cord blood</keyword>
	<keyword>Autologous cord blood</keyword>
	<keyword>cord blood</keyword>
</DOC>